Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.
Publication
, Journal Article
Wagner, MJ; Pollack, SM; Cranmer, LD; Thompson, MJ; Maxwell, S; Wright, S; Khaki, AR; Madeleine, MM; Grivas, P; Kuderer, NM; Lyman, GH; Loggers, ET
Published in: Cancer Invest
April 2021
Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24-69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6-41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20-62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.
Duke Scholars
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
April 2021
Volume
39
Issue
4
Start / End Page
315 / 320
Location
England
Related Subject Headings
- Young Adult
- Survival Analysis
- Soft Tissue Neoplasms
- Sarcoma
- SARS-CoV-2
- Risk Factors
- Retrospective Studies
- Outcome Assessment, Health Care
- Oncology & Carcinogenesis
- Middle Aged
Citation
APA
Chicago
ICMJE
MLA
NLM
Wagner, M. J., Pollack, S. M., Cranmer, L. D., Thompson, M. J., Maxwell, S., Wright, S., … Loggers, E. T. (2021). Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. Cancer Invest, 39(4), 315–320. https://doi.org/10.1080/07357907.2021.1903914
Wagner, Michael J., Seth M. Pollack, Lee D. Cranmer, Matthew J. Thompson, Shannon Maxwell, Stephanie Wright, Ali R. Khaki, et al. “Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.” Cancer Invest 39, no. 4 (April 2021): 315–20. https://doi.org/10.1080/07357907.2021.1903914.
Wagner MJ, Pollack SM, Cranmer LD, Thompson MJ, Maxwell S, Wright S, et al. Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. Cancer Invest. 2021 Apr;39(4):315–20.
Wagner, Michael J., et al. “Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.” Cancer Invest, vol. 39, no. 4, Apr. 2021, pp. 315–20. Pubmed, doi:10.1080/07357907.2021.1903914.
Wagner MJ, Pollack SM, Cranmer LD, Thompson MJ, Maxwell S, Wright S, Khaki AR, Madeleine MM, Grivas P, Kuderer NM, Lyman GH, Loggers ET. Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. Cancer Invest. 2021 Apr;39(4):315–320.
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
April 2021
Volume
39
Issue
4
Start / End Page
315 / 320
Location
England
Related Subject Headings
- Young Adult
- Survival Analysis
- Soft Tissue Neoplasms
- Sarcoma
- SARS-CoV-2
- Risk Factors
- Retrospective Studies
- Outcome Assessment, Health Care
- Oncology & Carcinogenesis
- Middle Aged